galanin-like peptide



galanin-like peptide

A1AA1P2PP2A3AA3H4HH4R5RR5G6GG6R7RR7G8GG8G9GG9W10WW10T11TT11L12LL12N13NN13S14SS14A15AA15G16GG16Y17YY17L18LL18L19LL19G20GG20P21PP21V22VV22L23LL23P24PP24V25VV25S26SS26S27SS27K28KK28A29AA29D30DD30Q31QQ31G32GG32R33RR33K34KK34R35RR35D36DD36S37SS37A38AA38L39LL39E40EE40I41II41L42LL42D43DD43L44LL44W45WW45K46KK46I47II47... and 13 more residue(s)...... and 13 more residue(s)

SMILES None
InChIKey None
Sequence APAHRGRGGWTLNSAGYLLGPVLPVSSKADQGRKRDSALEILDLWKIIDGLPYSHSPRMT

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

galanin-like peptide

A1AA1P2PP2A3AA3H4HH4R5RR5G6GG6R7RR7G8GG8G9GG9W10WW10T11TT11L12LL12N13NN13S14SS14A15AA15G16GG16Y17YY17L18LL18L19LL19G20GG20P21PP21V22VV22L23LL23P24PP24V25VV25S26SS26S27SS27K28KK28A29AA29D30DD30Q31QQ31G32GG32R33RR33K34KK34R35RR35D36DD36S37SS37A38AA38L39LL39E40EE40I41II41L42LL42D43DD43L44LL44W45WW45K46KK46I47II47... and 13 more residue(s)...... and 13 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.